John Schwieters Biography and Net Worth

Director of Danaher


Mr. Schwieters has served as Principal of Perseus TDC, a real estate investment and development firm, since July 2013. He also served as a Senior Executive of Perseus, LLC, a merchant bank and private equity fund management company, from May 2012 to June 2016 and as Senior Advisor from March 2009 to May 2012.

In addition to his roles with Perseus, Mr. Schwieters led the Mid-Atlantic region of one of the world’s largest accounting firms after previously leading that firm’s tax practice in the Mid-Atlantic region, and has served on the boards and chaired the audit committees of several NYSE-listed public companies. He brings to Danaher extensive knowledge and experience in the areas of public accounting, tax accounting and finance, which are areas of critical importance to Danaher as a large, global and complex public company.

What is John T. Schwieters' net worth?

The estimated net worth of John T. Schwieters is at least $5.98 million as of July 24th, 2020. Mr. Schwieters owns 25,394 shares of Danaher stock worth more than $5,976,986 as of April 20th. This net worth approximation does not reflect any other investments that Mr. Schwieters may own. Learn More about John T. Schwieters' net worth.

How do I contact John T. Schwieters?

The corporate mailing address for Mr. Schwieters and other Danaher executives is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. Danaher can also be reached via phone at (202) 828-0850 and via email at [email protected]. Learn More on John T. Schwieters' contact information.

Has John T. Schwieters been buying or selling shares of Danaher?

John T. Schwieters has not been actively trading shares of Danaher within the last three months. Most recently, John T. Schwieters sold 6,014 shares of the business's stock in a transaction on Friday, July 24th. The shares were sold at an average price of $193.95, for a transaction totalling $1,166,415.30. Following the completion of the sale, the director now directly owns 25,394 shares of the company's stock, valued at $4,925,166.30. Learn More on John T. Schwieters' trading history.

Who are Danaher's active insiders?

Danaher's insider roster includes Rainer Blair (EVP), Daniel Comas (EVP), William Daniel (EVP), Brian Ellis (SVP), Linda Filler (Director), Jose-Carlos Gutierrez-Ramos (SVP), Linda Hefner (Director), Jennifer Honeycutt (EVP), Thomas Joyce, Jr. (CEO), William King (SVP), Angela Lalor (SVP), Angela Lalor (SVP), Teri List (Director), Walter Lohr (Director), Robert Lutz (CAO), Matthew McGrew (CFO), Mitchell Rales (Chairman), Daniel Raskas (SVP), John Schwieters (Director), Alan Spoon (Director), Raymond Stevens (Director), Joakim Weidemanis (EVP), and Elias Zerhouni (Director). Learn More on Danaher's active insiders.

Are insiders buying or selling shares of Danaher?

In the last twelve months, insiders at the conglomerate sold shares 14 times. They sold a total of 115,345 shares worth more than $28,921,815.03. The most recent insider tranaction occured on February, 26th when SVP Daniel Raskas sold 23,757 shares worth more than $5,986,764.00. Insiders at Danaher own 11.1% of the company. Learn More about insider trades at Danaher.

Information on this page was last updated on 2/26/2024.

John T. Schwieters Insider Trading History at Danaher

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/24/2020Sell6,014$193.95$1,166,415.3025,394View SEC Filing Icon  
2/26/2018Sell10,578$100.30$1,060,973.4029,531View SEC Filing Icon  
5/28/2014Sell8,000$78.73$629,840.00View SEC Filing Icon  
See Full Table

John T. Schwieters Buying and Selling Activity at Danaher

This chart shows John T Schwieters's buying and selling at Danaher by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Danaher Company Overview

Danaher logo
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.
Read More

Today's Range

Now: $235.37
Low: $234.03
High: $237.80

50 Day Range

MA: $248.94
Low: $235.37
High: $256.19

2 Week Range

Now: $235.37
Low: $182.09
High: $259.00

Volume

2,351,264 shs

Average Volume

2,723,232 shs

Market Capitalization

$174.30 billion

P/E Ratio

36.83

Dividend Yield

0.45%

Beta

0.83